Monocytic Phagocytes in the Immunopathogenesis of Cytokine Storm Syndromes

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2024 Aug 8

PMID 39117814

Authors

Pui Y Lee

Affiliations

Soon will be listed here.

Abstract

Cytokine storm syndromes (CSSs) are caused by a dysregulated host immune response to an inciting systemic inflammatory trigger. This maladaptive and harmful immune response culminates in collateral damage to host tissues resulting in life-threatening multisystem organ failure. Knowledge of the various immune cells that contribute to CSS pathogenesis has improved dramatically in the past decade. Monocytes, dendritic cells, and macrophages, collective known as monocytic phagocytes, are well-positioned within the immune system hierarchy to make key contributions to the initiation, propagation, and amplification of the hyperinflammatory response in CSS. The plasticity of monocytic phagocytes also makes them prime candidates for mediating immunoregulatory and tissue-healing functions in patients who recover from cytokine storm-mediated immunopathology. Therefore, approaches to manipulate the myriad functions of monocytic phagocytes may improve the clinical outcome of CSS.

References

Auffray C, Sieweke M, Geissmann F . Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009; 27:669-92. DOI: 10.1146/annurev.immunol.021908.132557. View

Gordon S, Pluddemann A . The Mononuclear Phagocytic System. Generation of Diversity. Front Immunol. 2019; 10:1893. PMC: 6696592. DOI: 10.3389/fimmu.2019.01893. View

Bryant C, Gay N, Heymans S, Sacre S, Schaefer L, Midwood K . Advances in Toll-like receptor biology: Modes of activation by diverse stimuli. Crit Rev Biochem Mol Biol. 2015; 50(5):359-79. DOI: 10.3109/10409238.2015.1033511. View

Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite N . Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum. 2007; 56(11):3793-804. DOI: 10.1002/art.22981. View

Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R . Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011; 38(4):769-74. DOI: 10.3899/jrheum.100655. View

Graham R, Kozyrev S, Baechler E, Reddy M, Plenge R, Bauer J . A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006; 38(5):550-5. DOI: 10.1038/ng1782. View

Canna S, de Jesus A, Gouni S, Brooks S, Marrero B, Liu Y . An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014; 46(10):1140-6. PMC: 4177369. DOI: 10.1038/ng.3089. View

Romberg N, Al Moussawi K, Nelson-Williams C, Stiegler A, Loring E, Choi M . Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014; 46(10):1135-1139. PMC: 4177367. DOI: 10.1038/ng.3066. View

Canna S, Girard C, Malle L, de Jesus A, Romberg N, Kelsen J . Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. J Allergy Clin Immunol. 2016; 139(5):1698-1701. PMC: 5846100. DOI: 10.1016/j.jaci.2016.10.022. View

10.

Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G . Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2016; 76(1):166-172. DOI: 10.1136/annrheumdis-2015-209020. View

11.

Takada H, Takahata Y, Nomura A, Ohga S, Mizuno Y, Hara T . Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis. Clin Exp Immunol. 2003; 133(3):448-53. PMC: 1808805. DOI: 10.1046/j.1365-2249.2003.02237.x. View

12.

Moradinejad M, Ziaee V . The incidence of macrophage activation syndrome in children with rheumatic disorders. Minerva Pediatr. 2011; 63(6):459-66. View

13.

Behrens E, Beukelman T, Paessler M, Cron R . Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007; 34(5):1133-8. View

14.

Shimizu M, Nakagishi Y, Yachie A . Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013; 61(2):345-8. DOI: 10.1016/j.cyto.2012.11.025. View

15.

Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T . Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010; 49(9):1645-53. DOI: 10.1093/rheumatology/keq133. View

16.

Shimizu M, Yokoyama T, Tokuhisa Y, Ishikawa S, Sakakibara Y, Ueno K . Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin Immunol. 2013; 146(2):73-6. DOI: 10.1016/j.clim.2012.11.004. View

17.

Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T . IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol. 2000; 12(2):151-60. DOI: 10.1093/intimm/12.2.151. View

18.

Behrens E, Canna S, Slade K, Rao S, Kreiger P, Paessler M . Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011; 121(6):2264-77. PMC: 3104738. DOI: 10.1172/JCI43157. View

19.

Canna S, Wrobel J, Chu N, Kreiger P, Paessler M, Behrens E . Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum. 2013; 65(7):1764-75. PMC: 3708494. DOI: 10.1002/art.37958. View

20.

Weaver L, Chu N, Behrens E . TLR9-mediated inflammation drives a Ccr2-independent peripheral monocytosis through enhanced extramedullary monocytopoiesis. Proc Natl Acad Sci U S A. 2016; 113(39):10944-9. PMC: 5047205. DOI: 10.1073/pnas.1524487113. View